ENTERA BIO shares preclinical data for two pipeline drugs at ENDO 2026

June 16, 2026 8:33 AM

Entera Bio Ltd. (NASDAQ: ENTX) presented preclinical data for two pipeline candidates, EB612 and EB618, at ENDO 2026, the annual ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found